Edwards Lifesciences Corporation Stock Wiener Boerse
Stocks
EWLS
US28176E1082
Advanced Medical Equipment & Technology
|
End-of-day quote
Wiener Boerse
2026-09-17
|
5-day change | 1st Jan Change | ||
| 77.38 EUR | +0.99% |
|
+3.98% | +4.84% |
| 09-16 | Edwards Lifesciences Corporation Presents at Deutsche Bank 2026 Healthcare Summit, Sep-16-2026 10:00 AM | |
| 09-11 | Edwards Lifesciences Reaffirms 2026 Guidance Following Medicare TAVR Decision | MT |
| Market Cap | 50.87B 44.31B 41.93B 38.1B 71.17B 4,872B 71.52B 499B 193B 2,476B 191B 187B 7,926B | P/E 2026 * |
34.9x | P/E 2027 * | 26.7x |
|---|---|---|---|---|---|
| Enterprise Value | 47.24B 41.14B 38.94B 35.38B 66.09B 4,524B 66.42B 464B 179B 2,299B 177B 173B 7,360B | EV / Sales 2026 * |
6.99x | EV / Sales 2027 * | 6.15x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Tradegate
| EWL | Real-time | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Xetra
| EWL | Delayed | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +0.99% | ||
| 1 week | +3.98% | ||
| Current month | -1.15% | ||
| 1 month | -1.48% | ||
| 3 months | +0.91% | ||
| 6 months | +5.96% | ||
| Current year | +4.84% |
| 1 week | 72.94 |  | 78.24 |
| 1 month | 72.34 | | 79.44 |
| Current year | 64 | | 83.4 |
| 1 year | 61.81 | | 83.4 |
| 3 years | 54.5 | | 88.28 |
| 5 years | 54.5 | | 119 |
| 10 years | 49.79 | | 119 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.99% | +3.98% | - | - | 51.46B | |
| +1.53% | +9.14% | +39.29% | +27.70% | 240B | |
| +1.99% | +5.97% | +10.14% | -16.75% | 146B | |
| +0.33% | +6.40% | -11.56% | +29.78% | 135B | |
| -0.82% | +1.04% | -55.79% | -17.67% | 63.64B | |
| -1.15% | +1.71% | +17.35% | +20.56% | 51.46B | |
| +0.16% | 0.00% | -18.71% | -16.71% | 49.27B | |
| +1.72% | +9.24% | +23.37% | +34.88% | 43.33B | |
| +2.65% | +6.99% | +41.50% | +55.81% | 41.13B | |
| +7.10% | +21.82% | +143.07% | +67.76% | 34.57B | |
| Average | +1.40% | +5.66% | +20.96% | +20.59% | 89.41B | |
| Weighted average by Cap. | +1.19% | +6.57% | +16.69% | +16.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 5.89B 5.57B 5.06B 9.46B 647B 9.5B 66.37B 25.66B 329B 25.39B 24.83B 1,053B | 7.43B 6.47B 6.12B 5.56B 10.39B 711B 10.45B 72.94B 28.2B 362B 27.91B 27.29B 1,157B |
| Net income | 1.44B 1.25B 1.18B 1.07B 2.01B 137B 2.02B 14.09B 5.45B 69.85B 5.39B 5.27B 224B | 1.9B 1.65B 1.56B 1.42B 2.65B 182B 2.67B 18.62B 7.2B 92.32B 7.13B 6.97B 296B |
| Net Debt | -3.63B -3.16B -2.99B -2.72B -5.08B -348B -5.11B -35.65B -13.78B -177B -13.64B -13.34B -566B | -5.19B -4.52B -4.28B -3.89B -7.27B -498B -7.3B -51B -19.72B -253B -19.51B -19.08B -809B |
| Date | Price | Change |
|---|---|---|
| 26-09-17 | €77.38 | +0.99% |
| 26-09-16 | €76.62 | +3.68% |
| 26-09-15 | €73.90 | -0.22% |
| 26-09-14 | €74.06 | +2.38% |
| 26-09-11 | €72.34 | -2.79% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
- EWLS Stock
Select your edition
All financial news and data tailored to specific country editions
